Molte malattie metaboliche ereditarie possono essere diagnosticate a partire dai 65 anni.

I nostri risultati svelano meccanismi indipendenti da Gb3 nella progressione della malattia di Fabry e aprono la strada a nuove procedure diagnostiche...

Biomarcatori plasmatici come MCP-1, YKL-40 e Cistatina C offrono nuove prospettive sul monitoraggio della malattia di Fabry.

Questo studio evidenzia il potenziale del NBGS nel favorire la diagnosi precoce di LSD presintomatiche, permettendo interventi tempestivi e migliori...

A total of 79 hospitalized patients with CTCL were identified, including 52 (70.3%) men and 22 (29.7%) women, with a median (IQR) age at...

We aimed to examine specialist palliative care (SPC) involvement and end-of-life care for patients with MM

This retrospective cohort study used 2013-2018 commercial and Medicare claims data to assess medication use in adults with MM

To evaluate impact of time to transplant on subsequent outcomes, we analyzed data on consecutive MM patients who received novel agents-based induction...

Despite the introduction of new and better treatments, rapidly implemented in our countries, our registries uncover subgroups of patients that still...

Our study demonstrates that pre-existing hypertension was significantly associated with a lower PFS in newly diagnosed MM patients

Our results describe the mechanisms of miR-induced T-cell exhaustion, which provide a foundation for developing synthetic anti-miRs to therapeutically...